BDBM652472 N5-((6-((3-methyl-1,4,5,6-tetrahydrocyclopenta[c]pyrazol-6-yl)amino)pyridin-3- yl)methyl)isoquinoline-1,5-diamine::US20240059691, Example 1119

SMILES Cc1n[nH]c2c1CCC2Nc1ccc(CNc2cccc3c(N)nccc23)cn1

InChI Key InChIKey=KCYNEFNTFNRXFI-UHFFFAOYSA-N

Data  2 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 652472   

TargetPlasma kallikrein(Human)
Kalvista Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 652472BDBM652472(US20240059691, Example 1119 | N5-((6-((3-methyl-1,...)
Affinity DataIC50: 2.50E+4nMAssay Description:In vitro inhibition of related proteases was determined using an (C50 assay based on standard literature methods (see e.g. Shori et al., Biochem. Pha...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/24/2024
Entry Details
US Patent

TargetCoagulation factor XII(Human)
Kalvista Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 652472BDBM652472(US20240059691, Example 1119 | N5-((6-((3-methyl-1,...)
Affinity DataIC50: 2.50E+4nMAssay Description:In vitro inhibition of Factor XIIa was determined using an IC50 assay based on standard literature methods (see e.g Baeriswyl et al., ACS Chem. Biol....More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/24/2024
Entry Details
US Patent